We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+6.61%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.18B
AUM Growth
+$413M
Cap. Flow
+$293M
Cap. Flow %
7.01%
Top 10 Hldgs %
6.7%
Holding
1,500
New
123
Increased
567
Reduced
324
Closed
123

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$20M
2
NVDA icon
NVIDIA
NVDA
+$19M
3
JNJ icon
Johnson & Johnson
JNJ
+$14.9M
4
KO icon
Coca-Cola
KO
+$14.6M
5
MSFT icon
Microsoft
MSFT
+$13.7M

Sector Composition

Rank Sector Weight
1 Financials 24.63%
2 Consumer Discretionary 12.15%
3 Technology 12.08%
4 Industrials 12%
5 Healthcare 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANNX icon
1026
Annexon
ANNX
$918M
$326K 0.01%
+92,500
New +$404K
NTIC icon
1027
Northern Technologies International Corp
NTIC
$77.8M
$322K 0.01%
30,052
LOOP icon
1028
Loop Industries
LOOP
$32.9M
$320K 0.01%
99,400
PPSI
1029
Pioneer Power Solutions
PPSI
$33.5M
$320K 0.01%
+38,100
New +$228K
WLDN icon
1030
Willdan Group
WLDN
$1.11B
$320K 0.01%
+16,700
New +$281K
LSBK icon
1031
Lake Shore Bancorp
LSBK
$135M
$319K 0.01%
28,850
PLX icon
1032
Protalix BioTherapeutics
PLX
$197M
$318K 0.01%
158,790
+25,000
+19% +$59.6K
LVLU icon
1033
Lulu's Fashion Lounge
LVLU
$49.7M
$318K 0.01%
8,367
+1,700
+25% +$62.1K
POWW icon
1034
Outdoor Holding Co
POWW
$251M
$317K 0.01%
148,783
+3,038
+2% +$5.94K
CLSD
1035
DELISTED
Clearside Biomedical
CLSD
$313K 0.01%
18,640
-800
-4% -$13.8K
IVVD icon
1036
Invivyd
IVVD
$194M
$313K 0.01%
298,100
-10,000
-3% -$12.8K
SCWX
1037
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
$312K 0.01%
43,180
+20,000
+86% +$166K
VOR icon
1038
Vor Biopharma
VOR
$1.28B
$310K 0.01%
5,010
KORE
1039
DELISTED
KORE Group Holdings
KORE
$310K 0.01%
50,740
LEE icon
1040
Lee Enterprises
LEE
$181M
$305K 0.01%
22,670
VCSA
1041
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
$305K 0.01%
+22,500
New +$338K
CODX
1042
Co-Diagnostics
CODX
$5.23M
$303K 0.01%
9,097
-2,433
-21% -$93.1K
GOCO
1043
DELISTED
GoHealth
GOCO
$302K 0.01%
+15,336
New +$241K
FENC icon
1044
Fennec Pharmaceuticals
FENC
$377M
$302K 0.01%
34,200
STTK icon
1045
Shattuck Labs
STTK
$684M
$301K 0.01%
96,400
+11,200
+13% +$32.5K
SYY icon
1046
Sysco
SYY
$40.4B
$301K 0.01%
4,050
+250
+7% +$18.5K
KTCC icon
1047
Key Tronic
KTCC
$44.7M
$300K 0.01%
52,900
HDSN
1048
Hudson Technologies
HDSN
$238M
$298K 0.01%
30,939
-98,546
-76% -$857K
DNMR
1049
DELISTED
Danimer Scientific, Inc.
DNMR
$298K 0.01%
3,125
-903
-22% -$116K
TACT icon
1050
Transact Technologies
TACT
$58.4M
$296K 0.01%
33,000

Similar funds

Bridgeway Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Bridgeway Capital Management held 1,500 positions worth $4.18B, up 11% from $3.77B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.

Bridgeway Capital Management deployed $293M of net new capital in Q2 2023, opening 123 new positions and adding to 567 existing holdings. Its largest new stake was Tronox: 919,025 shares worth $11.7M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Permian Resources, an estimated $14.3M trimmed.

  • Bridgeway Capital Management's largest Q2 2023 buy was Tronox: 919,025 shares worth $11.7M.
  • Bridgeway Capital Management added most to JPMorgan Chase in Q2 2023, an estimated $20M increase.
  • Bridgeway Capital Management's biggest Q2 2023 reduction was Permian Resources, cutting an estimated $14.3M.
  • Bridgeway Capital Management fully exited TravelCenters of America LLC in Q2 2023, selling an estimated $21.5M.
  • Bridgeway Capital Management's ten largest holdings make up 6.7% of its $4.18B portfolio in Q2 2023.
  • Bridgeway Capital Management opened 123 new positions and closed 123 in Q2 2023.
  • Bridgeway Capital Management's portfolio value rose 11% quarter-over-quarter to $4.18B.

Based on Bridgeway Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.